Modulators Of Melanocortin Receptors For The Treatment Of Depression And Anxiety
Abstract
Compositions and methods for treating a depressive disorder or an anxiety disorder in a subject in need of such treatment are described herein. A therapeutically effective amount of a composition comprising a melanocortin 5 receptor (MC5R) peptide ligand according to the following: ##STR00001## in a pharmaceutically acceptable carrier is administered to the subject. Xaa can be Cha or Pro. The MC5R peptide is a selective MC5R antagonist, and administration thereof to the subject can treat the depressive or anxiety disorder with clinical improvement observed in a relatively short time.
Subject
A61K 9/0019A61K 9/7023
A61K 38/12
A61P 25/22
A61K 38/07
C07K 5/0202
A61K 9/0053
A61P 25/24
A61K 38/00
Collections
Citation
Hruby, Victor J.; Cai, Minying; Morgan, Caurnel (1/3/). Modulators Of Melanocortin Receptors For The Treatment Of Depression And Anxiety. United States. Patent and Trademark Office; Texas A&M University. Libraries. Available electronically from https : / /hdl .handle .net /1969 .1 /197560.